Myelodysplastic Syndrome (MDS)-Determining Clonal Events at Presentation of Aplastic Anemia (AA)

被引：0

作者：

Negoro, Eiju ^{[1
]}

Hosono, Naoko ^{[2
]}

Shen, Wenyi ^{[3
]}

Yoshizato, Tetsuichi ^{[4
]}

Patel, Bhumika J. ^{[1
]}

Hirsh, Cassandra ^{[1
]}

Przychodzen, Bartlomiej ^{[1
]}

Clemente, Michael J. ^{[1
]}

Mahfouz, Reda Z. ^{[1
]}

Wodnar-Filipowicz, Aleksandra ^{[5
]}

Makishima, Hideki ^{[4
]}

Ogawa, Seishi ^{[4
]}

Sekeres, Mikkael A. ^{[6
]}

Maciejewski, Jaroslaw P. ^{[1
]}

机构：

[1] Cleveland Clin, Taussing Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[2] Univ Fukui, Dept Hematol & Oncol, Fukui 910, Japan

[3] Nanjing Med Univ, Affilliated Hospitla 1, Nanjing, Jiangsu, Peoples R China

[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[5] Univ Basel Hosp, CH-4031 Basel, Switzerland

[6] Cleveland Clin, Leukemia Program, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] Human Telomerase Reverse Transcriptase (hTERT) Deficiency in Myelodysplastic Syndrome (MDS) Demonstrates Mechanistic Linkage to Aplastic Anemia Pathophysiology
Yang, Lili
Mailloux, Adam W.
Rollison, Dana E.
Park, Jong
Painter, Jeffrey S.
Komrokji, Rami S.
Maciejewski, Jaroslaw P.
Paquette, Ronald
Loughran, Thomas P., Jr.
Wei, Sheng
List, Alan F.
Epling-Burnette, Pearlie K.
BLOOD, 2011, 118 (21) : 359 - 360
[32] Aplastic Anemia Versus Hypoplastic Myelodysplastic Syndrome: A Diagnostic Dilemma
Afsari, Ali
Taddesse-Heath, Lekidelu
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S93 - S93
[33] Analysis of association of MHC with severe aplastic anemia and myelodysplastic syndrome
Nowak, J.
Mika-Witkowska, R.
Szlendak, U.
Dlugokecka, A.
Marosz-Rudnicka, A.
Jezewska, M.
Graczyk-Pol, E.
Skulimowska, J.
Onufrzak, I.
TISSUE ANTIGENS, 2011, 77 (05): : 504 - 504
[34] THE DIFFERENTIAL DIAGNOSIS BETWEEN APLASTIC ANEMIA AND HYPOCELLULAR MYELODYSPLASTIC SYNDROME
Wu, J. H.
Xue, L.
Lv, Y. F.
Gao, H.
Wang, K. K.
Song, J.
Yin, S. F.
Zhou, Y.
Zhang, X. Y.
Cao, Y. Z.
Wang, Q.
Yuan, X.
Song, Y.
Wang, G. L.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 : 24 - +
[35] Clonal T cell expansion in high risk myelodysplastic syndrome (MDS).
Painter, JS
Bai, FQ
Cantor, A
List, AF
Epling-Burnette, PK
BLOOD, 2005, 106 (11) : 959A - 959A
[36] In vitro antithymocyte globulin (ATG) stimulation of hemopoietic stem cells: Correlation with clinical response in patients with aplastic anemia (AA) and myelodysplastic syndromes (MDS).
Killick, S
Marsh, JCW
Gordon-Smith, EC
Gibson, FM
BLOOD, 1998, 92 (10) : 693A - 693A
[37] Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST).
Führer, M
Rampf, U
Bender-Götze, C
BONE MARROW TRANSPLANTATION, 1999, 23 : S29 - S29
[38] Sclerosing mesenteritis as a presentation of myelodysplastic syndrome (MDS) with improvement following treatment targeted at MDS
Elnair, Radowan
Sethi, Prince
Hassouna, Tarek
Galal, Ahmed
ANNALS OF HEMATOLOGY, 2018, 97 (03) : 547 - 549
[39] Sclerosing mesenteritis as a presentation of myelodysplastic syndrome (MDS) with improvement following treatment targeted at MDS
Radowan Elnair
Prince Sethi
Tarek Hassouna
Ahmed Galal
Annals of Hematology, 2018, 97 : 547 - 549
[40] Transplantation from haploidentical allogeneic donors for severe aplastic anemia (SAA) and myelodysplastic syndromes (MDS).
Abhyankar, S
Godder, K
Chiang, KY
Christiansen, N
Hazlett, L
Adams, S
Henslee-Downey, PJ
BLOOD, 1999, 94 (10) : 561A - 561A

← 1 2 3 4 5 →